Business
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
MARSEILLE, France, May 27, 2025--Innate Pharma announces its participation in upcoming investor conferences
About this update from Innate Pharma Sa Class A
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/7226bf9ea4fceee9daeaec1f09219606"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/PEkyzUeJzqATzHSk5WBbpg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/7226bf9ea4fceee9daeaec1f09219606","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/FraYjYAuavgZIc..JtqJoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/7226bf9ea4fceee9daeaec1f09219606","width":1024,"height":512}},"lazy":false},{"type":"text","content":"MARSEILLE, France, May 27, 2025--(BUSINESS WIRE)--Regulatory News:","length":66,"tagName":"p"},{"type":"text","content":"Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team will present and host 1x1 meetings at the upcoming investor conferences, detailed below.","length":240,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Jefferies Global Healthcare ConferenceDates: June 3 – 5 2025 | New York, USA","length":77,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":77,"olType":false},{"type":"text","content":"The executive team will participate in a fireside chat scheduled on Thursday, June 5, 2025, from 7:35 to 8:05 am EDT.","length":117,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Goldman Sachs 46th Annual Global Healthcare ConferenceDates: June 9 – 11 2025 | Miami, USA","length":91,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":91,"olType":false},{"type":"text","content":"The executive team will participate in a fireside chat scheduled on Tuesday, June 10, 2025, from 4:00 to 4:35 pm EDT.","length":117,"tagName":"p"},{"type":"text","content":"In addition, members of the executive team will participate and represent the Company during the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting being held from May 30 to June 3, 2025 in Chicago, Illinois.","length":222,"tagName":"p"},{"type":"text","content":"About Innate Pharma","length":19,"tagName":"p"},{"type":"text","content":"Innate Pharma...